Sanford Health is a non-profit, integrated health care delivery system, with its headquarters in Sioux Falls, South Dakota, with additional offices in Fargo and Bismarck, North Dakota, and Bemidji, Minnesota.

During the past decade, Sanford Health conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 10 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 8 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanford Health" #1 sponsor was "Sanford Health" with 11 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Actelion" with 2 trials sponsored, "Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanford Health" #1 collaborator was "Sanford Health" with 2 trials as a collaborator, "University of North Dakota" with 2 trials as a collaborator, "1p36 Deletion Support and Awareness" with 1 trials as a collaborator, "4p- Support Group" with 1 trials as a collaborator and "All Things Kabuki" with 1 trials as a collaborator. Other collaborators include 133 different institutions and companies that were collaborators in the rest 143 trials.

According to Clinical.Site data, the most researched conditions in "Sanford Health" are "Breast Cancer" (4 trials), "COVID-19" (3 trials), "Melanoma" (3 trials), "Solid Tumor" (3 trials) and "Cancer" (2 trials). Many other conditions were trialed in "Sanford Health" in a lesser frequency.

Most popular intervention types in "Sanford Health" are "Drug" (27 trials), "Biological" (9 trials), "Device" (8 trials), "Other" (7 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Carboplatin" (4 trials), "Amivantamab" (2 trials), "Macitentan 10 mg" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sanford Health" are 44 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Sanford Health". undefined are not yet recruiting, 19 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Sanford Health, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Sanford Health, 7 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".